Novavax Inc (STU:NVV1)
€ 13.352 1.6 (13.61%) Market Cap: 1.95 Bil Enterprise Value: 1.72 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 72/100

Novavax Inc at Jefferies London Healthcare Conference Transcript

Nov 15, 2023 / 09:00AM GMT
Release Date Price: €5.79 (+1.69%)
Roger Song
Jefferies LLC, Research Division - Equity Associate

Welcome to Day 2 at Jefferies Healthcare Conference in London. My name is Roger Song, one of the senior analysts who covers Biotech at Jefferies in the U.S. Next presenting company is Novavax. Welcome, John, Filip, and Jim.

John Charles Jacobs
Novavax, Inc. - President, CEO & Director

Thank you, Roger.

Filip Dubovsky
Novavax, Inc. - President of Research & Development

Hey, Roger.

James Patrick Kelly
Novavax, Inc. - Executive VP, CFO & Treasurer

Thanks, Roger.

Questions & Answers

Roger Song;John Charles
Jefferies LLC, Research Division - Equity Associate

Awesome. So maybe we kick this off right now. So maybe, John, as a relatively new CEO, but you have been with Novavax for a couple of months already, what is your updated elevator pitch for Novavax with the recent kind of a strategic priority you lay out for the company?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot